Aurora, CONCT04043520Now EnrollingIRB Ready

Menopause Clinical Trial in Aurora, CO

Access cutting-edge menopause treatment through this phase 4 clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by University of Colorado, Denver

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access menopause specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related menopause treatment provided free

Apply for This Aurora Location

Check if you qualify for this menopause clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Menopause Study in Aurora

The menopause transition is associated with increased risk for weight gain and a shift toward storing fat in the belly region, which may increase risk for cardiovascular disease and diabetes. The study will determine whether the stress hormone cortisol contributes to this shift.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Volunteers will be healthy peri/postmenopausal women who are willing and able to undergo the proposed hormone manipulation and study procedures. Women will be at least 6 months but not more than 7 years past the last menstrual period (i.e., late perimenopausal or early postmenopausal) with FSH \>30 IU/L. We will make a major effort to ensure that the women enrolled in this study come from all races and ethnicities and a wide range of socioeconomic and educational levels. Women will be excluded for the reasons listed below.

Exclusion Criteria

abnormal vaginal bleeding
on hormonal contraceptive or menopausal therapy or intention to start during the period of study
positive pregnancy test or intention to become pregnant during the period of study
known hypersensitivity to degarelix acetate, estradiol, or medroxyprogesterone acetate
Center for Epidemiological Studies Depression Scale (CES-D) score \<,16 (unless clinician follow-up and clinical judgement determine they are eligible (will be noted in study chart)
current tobacco and/or vape use more than 2 times/week
current marijuana or tetrahydrocannabinol (THC) use in any form more than 3 times/week
regular self-reported alcohol consumption \>14 drinks/week
BMI \>39 kg/m2
use of glucocorticoids or drugs that affect glucocorticoid metabolism (e.g., ketoconazole)
severe osteopenia or osteoporosis, defined as femoral neck or lumbar spine t-score \<-2.0
thyroid dysfunction, defined as an ultrasensitive TSH \<0.5 or \>5.0 mU/L; volunteers with abnormal thyroid stimulating hormone (TSH) values will be re-considered for participation in the study after follow-up evaluation by the PCP with initiation or adjustment of thyroid hormone replacement
liver dysfunction, defined as liver function tests (AST, ALT) \>1.5 times the upper limit of normal
uncontrolled hypertension defined as resting systolic BP \>150 mmHg or diastolic BP\>90 mmHg; participants who do not meet these criteria at first screening will be re-evaluated, including after follow-up evaluation by the primary care provider (PCP) with initiation or adjustment of anti-hypertensive medications
self-reported history of breast cancer or other estrogen-dependent neoplasms
self-reported history of venous thromboembolism, pulmonary embolism, or other thromboembolic disorder
self-reported history of cardiovascular disease

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT04043520) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Menopause Treatment Options in Aurora, CO

If you're searching for menopause treatment options in Aurora, CO, this clinical trial (NCT04043520) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced menopause specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all menopause clinical trials near you to find additional studies recruiting in your area.

More Menopause Trials in Aurora, CO

See all menopause clinical trials recruiting in Aurora — not just this study.

Browse Menopause Trials in Aurora →

Browse More Trials by Condition

Menopause TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO